Haskin O, Lazar L, Jaber L, Salvatori R, Alba M, Kornreich L, Phillip M, Gat-Yablonski G
Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes Petach Tikva, Israel.
J Endocrinol Invest. 2006 Feb;29(2):122-30. doi: 10.1007/BF03344084.
Mutations in the GHRH receptor gene (GHRH-R) are emerging as a common cause of familial isolated GH deficiency (IGHD).
We searched for GHRH-R mutations in 10 patients with IGHD of Israeli-Arab origin, belonging to two highly consanguineous families.
Analysis of the 13 coding exons, the intron-exon boundaries, and the proximal promoter of the GHRH-R was performed by denaturing gradient gel electrophoresis. Abnormally migrating bands were sequenced. The newly found mutation was inserted into GHRH-R cDNA. Wild type and mutant receptor were expressed in Chinese hamster ovary (CHO) cells, and the cAMP response to GHRH was measured.
All patients were homozygous for a novel GHRH-R missense mutation in exon 11 that replaces arginine with cysteine (R357C). Functional assay demonstrated complete inactivity of the mutant receptor in vitro. The prevalence of the mutant allele in the Israeli-Arab population was found to be 2%. All the patients had low but detectable GH reserve, proportionate short stature, and growth retardation since early childhood, with good growth response to GH treatment. Magnetic resonance imaging, performed in 3 patients, revealed a normal sized anterior pituitary in one patient evaluated at early childhood, and a borderline hypoplastic gland in the 2 patients evaluated at puberty.
We describe a novel missense mutation in the GHRH-R. The high incidence of the mutant allele in Israeli Arabs suggests that the mutation may be a common cause of familial IGHD in this population.
生长激素释放激素受体基因(GHRH-R)突变正逐渐成为家族性孤立性生长激素缺乏症(IGHD)的常见病因。
我们在10名来自以色列阿拉伯裔的IGHD患者中寻找GHRH-R突变,这些患者来自两个高度近亲通婚的家族。
通过变性梯度凝胶电泳对GHRH-R的13个编码外显子、内含子-外显子边界和近端启动子进行分析。对迁移异常的条带进行测序。将新发现的突变插入GHRH-R cDNA。野生型和突变型受体在中国仓鼠卵巢(CHO)细胞中表达,并测量对GHRH的cAMP反应。
所有患者均为外显子11中一种新的GHRH-R错义突变的纯合子,该突变用半胱氨酸取代精氨酸(R357C)。功能测定表明突变型受体在体外完全无活性。发现突变等位基因在以色列阿拉伯人群中的患病率为2%。所有患者自幼儿期起生长激素储备低但可检测到,身材匀称矮小且生长发育迟缓,对生长激素治疗有良好的生长反应。对3名患者进行的磁共振成像显示,1名幼儿期接受评估的患者垂体前叶大小正常,2名青春期接受评估的患者腺体呈临界发育不全。
我们描述了一种新的GHRH-R错义突变。突变等位基因在以色列阿拉伯人中的高发生率表明该突变可能是该人群中家族性IGHD的常见病因。